744 Indolent clinical outcomes of carcinoma in situ-associated pTa bladder tumour after bacillus Calmette-Guérine: Need for a new classification of carcinoma in situ

S.J. Kim,S. Hong,H.J. Kim,D. You,I.G. Jeong,C. Song,B.S. Hong,C.S. Kim,H. Ahn,J.H. Hong; S.J. Kim; S. Hong; H.J. Kim; D. You; I.G. Jeong; C. Song; B.S. Hong; C.S. Kim; H. Ahn; J.H. Hong

744 Indolent clinical outcomes of carcinoma in situ-associated pTa bladder tumour after bacillus Calmette-Guérine: Need for a new classification of carcinoma in situ

S.J. Kim,S. Hong,H.J. Kim,D. You,I.G. Jeong,C. Song,B.S. Hong,C.S. Kim,H. Ahn,J.H. Hong;S.J. Kim;S. Hong;H.J. Kim;D. You;I.G. Jeong;C. Song;B.S. Hong;C.S. Kim;H. Ahn;J.H. Hong;

european urology supplements 2016 Vol. 15 pp. e744-

100

hong2016european744

Keywords

new classification indolent clinical pta bladder associated pta bladder tumour calmette gurine situ associated

Access

DOI:

10.1016/s1569-9056(16)60746-7

URL:

https://sciprofiles.com/publication/view/b1131bc13...

Citation

ID: 269473

Ref Key: hong2016european744

Use this key to autocite in SciMatic or Thesis Manager

References

No Bibliography

Blockchain Verification

Account:

NFT Contract Address:

0x95644003c57E6F55A65596E3D9Eac6813e3566dA

Article ID:

269473

Unique Identifier:

10.1016/s1569-9056(16)60746-7

Network:

Scimatic Chain (ID: 481)

Blockchain Readiness Checklist

Authors

Abstract

Journal Name

Year

Title

4/5

Blockchain Upload Locked

Complete all 5 checklist items to tokenize your article

Gas fees required in SCI Coins

Buy SCI

Saymatik Web3.0 Wallet

Google Play

App Store

744 Indolent clinical outcomes of carcinoma in situ-associated pTa bladder tumour after bacillus Calmette-Guérine: Need for a new classification of carcinoma in situ

Keywords

Access

Citation

References

References

Blockchain Verification

Blockchain Readiness Checklist

Saymatik Web3.0 Wallet

About

Services

Legal

License